title: The European Society of Gynecologic Oncology (ESGO) 19th biannual meeting: Overview and summary of selected topics.
authors.affiliation: Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: swestin@mdanderson.org.
authors.forename: Shannon N
authors.initials: SN
authors.lastname: Westin
authors.affiliation: Division of Gynecologic Oncology, University of California, Irvine, Los Angeles, CA, United States.
authors.forename: Leslie
authors.initials: L
authors.lastname: Randall
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001011:Aorta; D017024:Chemotherapy, Adjuvant; D019008:Drug Resistance, Neoplasm; D016889:Endometrial Neoplasms / Q000737:chemistry / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000032:analysis; D010535:Laparoscopy; D008197:Lymph Node Excision / Q000009:adverse effects*; D008207:Lymphatic Metastasis; D008210:Lymphocele / Q000209:etiology*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D010388:Pelvis; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D024162:Second-Look Surgery; D002583:Uterine Cervical Neoplasms / Q000628:therapy*
chemical_list: C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit
keywords: 2015; ESGO; Gynecologic cancer; Meeting